Todd E. Simpson
2017
In 2017, Todd E. Simpson earned a total compensation of $3.1M as Chief Financial Officer at Seattle Genetics, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $264,076 |
|---|---|
| Option Awards | $1,101,374 |
| Salary | $492,208 |
| Stock Awards | $1,191,510 |
| Other | $12,630 |
| Total | $3,061,798 |
Simpson received $1.2M in stock awards, accounting for 39% of the total pay in 2017.
Simpson also received $264.1K in non-equity incentive plan, $1.1M in option awards, $492.2K in salary and $12.6K in other compensation.
Rankings
In 2017, Todd E. Simpson's compensation ranked 3,551st out of 14,666 executives tracked by ExecPay. In other words, Simpson earned more than 75.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,551 out of 14,666 | 76th |
Division Manufacturing | 1,225 out of 5,772 | 79th |
Major group Chemicals And Allied Products | 339 out of 2,075 | 84th |
Industry group Drugs | 260 out of 1,731 | 85th |
Industry Biological Products, Except Diagnostic Substances | 48 out of 313 | 85th |
Source: SEC filing on April 3, 2018.
Simpson's colleagues
We found seven more compensation records of executives who worked with Todd E. Simpson at Seattle Genetics in 2017.
2017
Clay Siegall
Seattle Genetics
Chief Executive Officer
2017
Eric Dobmeier
Seattle Genetics
Chief Operating Officer
2017
Jonathan Drachman
Seattle Genetics
Chief Medical Officer
2017
Vaughn Himes
Seattle Genetics
Chief Technical Officer
2017
Jean Liu
Seattle Genetics
General Counsel
2017
Jean Liu
Seattle Genetics
General Counsel
2017
Darren Cline
Seattle Genetics